RESEARCH BASE
Search 3,721 documents across 34 fields — every claim tier-rated by evidence
3,633 are the core, quality-scored corpus (34 lettered sections — see How We Work); the remaining 88 are cross-corpus synthesis documents (68 InterDocs, 12 Connections, 8 Theories) also indexed here.
263 results for "psychedelic medicine" — page 3 of 14
K_3_17 — Psychedelic Consciousness — DMT, Psilocybin Neural Effects
The psychedelic renaissance in neuroscience — a period of renewed scientific investigation beginning circa 2006 after decades of regulatory restriction — has produced an unprecedented body of neuroimaging, pharmacologica
K_5_03 — Psychosomatic Medicine and Mind–Body Interaction
Psychosomatic medicine investigates the bidirectional relationship between psychological processes and physical health — how mental states, emotions, beliefs, and social contexts influence bodily disease, and how physica
J_4_02 — Ancient Medicine and Healing Traditions
Ancient healing traditions represent some of humanity's most sophisticated technological achievements, yet are frequently underestimated by modern observers who conflate ritual context with practical ineffectiveness. Egy
INTERDOC_20 — Psychedelic Neuroscience and Ancient Ritual Practice
[KEY FINDING] The Johns Hopkins Center for Psychedelic and Consciousness Research, the Imperial College Centre for Psychedelic Research (est. 2019, directed by Robin Carhart-Harris), and the MAPS (Multidisciplinary Assoc
L_5_03 — Pharmacogenomics and Ancestral Medicine
Pharmacogenomics — the study of how genetic variation influences individual responses to drugs — bridges genetics, pharmacology, and clinical medicine. Humans carry extensive polymorphism in genes encoding drug-metaboliz
Y_1_04 — Psychedelic Renaissance — Clinical Research and Consciousness
The psychedelic renaissance — a resurgence of rigorous scientific research on psychedelic substances after decades of prohibition — has produced some of the most significant findings in 21st-century psychiatry and consci
Y_1_06 — Psychedelic Research — Modern Science and Ancient Entheogen Parallels
Psychedelic research has undergone a dramatic revival since ~2006, with major studies at Johns Hopkins, Imperial College London, NYU, and MAPS demonstrating the therapeutic potential of psilocybin, MDMA, and ayahuasca/DM
Y_1_15 — Micro-Dosing: Sub-Perceptual Psychedelic Use and Cognitive Effects
Micro-dosing — the practice of regularly consuming sub-perceptual doses (typically 1/10th to 1/20th of a standard recreational dose) of psychedelic substances, most commonly LSD (~10–20 micrograms) or psilocybin (~0.1–0.
Y_1_16 — Psychedelic Legal Frameworks: Regulation, Decriminalization, and Therapeutic Access
The legal status of psychedelic substances — including psilocybin, LSD, MDMA, DMT/ayahuasca, mescaline, and ibogaine — has undergone dramatic shifts since the mid-20th century, moving from unregulated research compounds
Y_1_01 — Altered States, Psychedelics & Ancient Knowledge
Psychoactive substances played a significant — possibly central — role in ancient knowledge traditions. The Eleusinian Mysteries (kykeon), Vedic tradition (Soma), Egyptian practice (blue lotus), and Mesoamerican religion
H_4_06 — Suppression of Psychedelic Research (1960s–2000s)
From the late 1940s through the mid-1960s, psychedelic substances — particularly LSD (lysergic acid diethylamide) and psilocybin — were the subject of extensive legitimate scientific research, with over 1,000 peer-review
ZE_3_06 — Ethics of Psychedelic Research and Therapy
The ethics of psychedelic research and therapy addresses the unique moral challenges posed by substances that profoundly alter consciousness in therapeutic, religious, and research contexts. After a 40-year research mora
S_2_12 — Personalized Medicine: Pharmacogenomics and Precision Health
Personalized medicine (also called precision medicine) tailors medical treatment to the individual characteristics of each patient — particularly their genetic makeup, but also incorporating biomarkers, environmental fac
S_2_06 — Regenerative Medicine and Bioprinting
Regenerative medicine aims to repair, replace, or regenerate damaged tissues and organs using biological approaches — tissue engineering, stem cell therapy, bioprinting, and xenotransplantation. The organ shortage crisis
X_5_27 — Stem Cell Medicine and Regenerative Therapy
Stem cell medicine — the therapeutic use of cells capable of self-renewal and differentiation into specialized cell types — has progressed from a theoretical concept to clinical reality over six decades. James Till and E
X_3_21 — Pulmonology & Respiratory Medicine
Pulmonology encompasses the diagnosis and treatment of disease affecting the respiratory system — from upper airways to alveolar gas exchange. Respiratory diseases collectively represent the third leading cause of death
INTERDOC_72 — The Psychedelic Entropy Paradox: Coherence Through Anarchy
The "Entropic Brain" hypothesis, pioneered by Robin Carhart-Harris (Imperial College London), demonstrates that under the influence of classic psychedelics (psilocybin, LSD, DMT), the brain's Default Mode Network (DMN) d
Z_4_06 — Psychedelic Neurochemistry: 5-HT2A, Tryptamines, and Molecular Mechanisms
Psychedelic neurochemistry — the molecular-level study of how psychedelic compounds alter brain function to produce their characteristic effects (visual hallucinations, synesthesia, ego dissolution, mystical-type experie
Y_1_21 — Plant Medicine & Alkaloid Chemistry
Alkaloids — nitrogen-containing organic compounds produced by plants as secondary metabolites — constitute one of the most important classes of biologically active molecules in both medicine and human culture. Over 20,00
A_3_05 — Ancient Egyptian Medical and Scientific Papyri
Ancient Egyptian medical and scientific papyri constitute the earliest known systematic attempts at empirical investigation of the human body, disease, and the natural world. The Edwin Smith Papyrus (~1600 BCE, copied fr
BROWSE BY SECTION — 3,721 documents across 34 fields